SCHEMBL21928556

SCHEMBL21928556

N#Cc1ccc(-c2c(-n3c4ccccc4c4ccc5c(c6ccccc6n5-c5ccccc5)c43)cncc2-n2c3ccccc3c3ccc4c(c5ccccc5n4-c4ccccc4)c32)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MAPK1 P28482 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32
▸ GABRA5 P31644 1/20 0.32
▸ GABRA3 P34903 1/20 0.32
▸ PTGER4 P35408 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ PDPK1 O15530 1/20 0.31
▸ CYP11B2 P19099 2/20 0.31
▸ PGR P06401 1/20 0.31
▸ USP14 P54578 1/20 0.31
▸ AR P10275 2/20 0.30
▸ CYP11B1 P15538 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21928558 0.90 ATM (0.40) ATMKDM4EL3MBTL1MAPK1KMT2A
SCHEMBL21929246 0.90 GABRA1 (0.37) ATMKDM4EL3MBTL1MAPK1KMT2A
SCHEMBL21928557 0.87 GABRP (0.38) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL24510015 0.86 ATM (0.41) ATMKDM4EL3MBTL1KMT2AMEN1
SCHEMBL17297077 0.85 ATM (0.45) ATMKDM4EL3MBTL1KMT2AGABRA1
SCHEMBL24510052 0.84 ATM (0.39) ATMKDM4EL3MBTL1KMT2APTGER4
SCHEMBL26473248 0.84 KDM4E (0.49) ATMKDM4EL3MBTL1PTGER4USP14
SCHEMBL21928659 0.84 ATM (0.41) ATMKDM4EL3MBTL1MAPK1KMT2A
SCHEMBL23098065 0.83 KDM4E (0.38) ATMKDM4EL3MBTL1GABRG2GABRB3
SCHEMBL21950282 0.83 KDM4E (0.38) ATMKDM4EL3MBTL1KMT2APTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 — — US disclosed
EP-3609978-B1 ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-03-17 — — EP disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 ATM 3885/4885KDM4E 1828/4885L3MBTL1 3911/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA ATM 2895/4885KDM4E 4010/4885L3MBTL1 1668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback